-
1
-
-
27144519144
-
-
Toms JR Ed, Cancer Research UK, London, UK
-
CancerStats Monograph 2004. Toms JR (Ed.). Cancer Research UK, London, UK (2004).
-
(2004)
CancerStats Monograph 2004
-
-
-
2
-
-
50249123088
-
Pathology and Genetics of Tumours of Soft Tissue and Bone
-
World Health Organisation Classification of Tumours:, Eds, IARC Press, Lyon, France
-
World Health Organisation Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Fletcher CDM, Unni KK, Mertens F (Eds). IARC Press, Lyon, France (2002).
-
(2002)
Fletcher CDM, Unni KK, Mertens F
-
-
-
3
-
-
0021366779
-
Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system
-
Trojani M, Contesso G, Coindre JM et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int. J. Cancer 33, 37-42 (1984).
-
(1984)
Int. J. Cancer
, vol.33
, pp. 37-42
-
-
Trojani, M.1
Contesso, G.2
Coindre, J.M.3
-
4
-
-
0022455098
-
Reproducibility of a histopathologic grading system for adult soft tissue sarcoma
-
Coindre JM, Trojani M, Contesso G et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 58(2), 306-309 (1986).
-
(1986)
Cancer
, vol.58
, Issue.2
, pp. 306-309
-
-
Coindre, J.M.1
Trojani, M.2
Contesso, G.3
-
5
-
-
0031023138
-
Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma
-
Guillou L, Coindre JM, Bonichon F et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J. Clin. Oncol. 15(1), 350-362 (1997).
-
(1997)
J. Clin. Oncol
, vol.15
, Issue.1
, pp. 350-362
-
-
Guillou, L.1
Coindre, J.M.2
Bonichon, F.3
-
6
-
-
0025834367
-
Adjuvant therapy for adult patients with soft tissue sarcomas
-
Delaney TF, Yang JC, Glatstein E. Adjuvant therapy for adult patients with soft tissue sarcomas. Oncology 5, 105-118 (1991).
-
(1991)
Oncology
, vol.5
, pp. 105-118
-
-
Delaney, T.F.1
Yang, J.C.2
Glatstein, E.3
-
7
-
-
0030696320
-
Variable management of soft tissue sarcomas: Regional audit with implications for specialist care
-
Clasby R, Tilling K, Smith MA, Fletcher CDM. Variable management of soft tissue sarcomas: regional audit with implications for specialist care. Br. J. Surg. 84, 1692-1696 (1997).
-
(1997)
Br. J. Surg
, vol.84
, pp. 1692-1696
-
-
Clasby, R.1
Tilling, K.2
Smith, M.A.3
Fletcher, C.D.M.4
-
8
-
-
0019977912
-
The treatment of soft tissue sarcomas of the extremities. prospective randomised evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy
-
Rosenberg SA, Tepper J, Glatstein E et al. The treatment of soft tissue sarcomas of the extremities. prospective randomised evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann. Surg. 196, 305-315 (1982).
-
(1982)
Ann. Surg
, vol.196
, pp. 305-315
-
-
Rosenberg, S.A.1
Tepper, J.2
Glatstein, E.3
-
9
-
-
0023913082
-
Treatment of the patient with stage M0 soft tissue sarcoma
-
Suit HD, Mankin HJ, Wodd WC et al. Treatment of the patient with stage M0 soft tissue sarcoma. J. Clin. Oncol. 6(5), 854-862 (1988).
-
(1988)
J. Clin. Oncol
, vol.6
, Issue.5
, pp. 854-862
-
-
Suit, H.D.1
Mankin, H.J.2
Wodd, W.C.3
-
10
-
-
0031566814
-
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data
-
Sarcoma Meta-analysis Collaboration
-
Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 350, 1647-1654 (1997).
-
(1997)
Lancet
, vol.350
, pp. 1647-1654
-
-
-
11
-
-
0842269242
-
p53 family members and chemoresistance in cancer: What we know and what we need to know
-
Gasco M, Crook T. p53 family members and chemoresistance in cancer: what we know and what we need to know. Drug Resist. Updat. 6, 323-328 (2003).
-
(2003)
Drug Resist. Updat
, vol.6
, pp. 323-328
-
-
Gasco, M.1
Crook, T.2
-
12
-
-
0034092081
-
Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma
-
Coley HM, Verrill MW, Gregson SE, Odell DE, Fisher C, Judson IR. Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma. Eur. J. Cancer 36(7), 881-888 (2000).
-
(2000)
Eur. J. Cancer
, vol.36
, Issue.7
, pp. 881-888
-
-
Coley, H.M.1
Verrill, M.W.2
Gregson, S.E.3
Odell, D.E.4
Fisher, C.5
Judson, I.R.6
-
13
-
-
31544477155
-
Adult soft tissue sarcomas: Conventional therapies and molecularly targeted approaches
-
Mocellin S, Rossi CR, Brandes A, Nitti D. Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches. Cancer Treat. Rev. 32, 9-27 (2006).
-
(2006)
Cancer Treat. Rev
, vol.32
, pp. 9-27
-
-
Mocellin, S.1
Rossi, C.R.2
Brandes, A.3
Nitti, D.4
-
14
-
-
0025633582
-
Germline p53 mutations in a Familial syndrome of breast cancer, sarcomas and other neoplasms
-
Malkin D, Li FP, Strong LC et al. Germline p53 mutations in a Familial syndrome of breast cancer, sarcomas and other neoplasms. Science, 250, 1233-1238 (1990).
-
(1990)
Science
, vol.250
, pp. 1233-1238
-
-
Malkin, D.1
Li, F.P.2
Strong, L.C.3
-
15
-
-
0014587529
-
Soft tissue sarcomas, breast cancer and other neoplasms. A familial syndrome?
-
Li FP, Fraumeni JF. Soft tissue sarcomas, breast cancer and other neoplasms. A familial syndrome? Ann. Intern. Med. 71, 747-752 (1969).
-
(1969)
Ann. Intern. Med
, vol.71
, pp. 747-752
-
-
Li, F.P.1
Fraumeni, J.F.2
-
16
-
-
0023715595
-
A cancer family syndrome in twenty foar kindreds
-
Li FP, Fraumeni JF, Mulvihill JJ et al. A cancer family syndrome in twenty foar kindreds. Cancer Res. 48, 5358-5362 (1988).
-
(1988)
Cancer Res
, vol.48
, pp. 5358-5362
-
-
Li, F.P.1
Fraumeni, J.F.2
Mulvihill, J.J.3
-
17
-
-
0031453254
-
Consequences of chromosomal abormalities in tumor development
-
Sanchez-Garcia I. Consequences of chromosomal abormalities in tumor development. Ann. Rev. Genet. 31, 429-453 (1997).
-
(1997)
Ann. Rev. Genet
, vol.31
, pp. 429-453
-
-
Sanchez-Garcia, I.1
-
18
-
-
3142647035
-
Changing concepts in the pethological basis of soft tissue and bone sarcoma treatment
-
Hogendoorn PCW, Collin F, Daugaard S et al. Changing concepts in the pethological basis of soft tissue and bone sarcoma treatment. Eur. J. Cancer 40, 1644-1654 (2004).
-
(2004)
Eur. J. Cancer
, vol.40
, pp. 1644-1654
-
-
Hogendoorn, P.C.W.1
Collin, F.2
Daugaard, S.3
-
19
-
-
7044234953
-
Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: A multicenter, retrospective analysis
-
Guillou L, Benhattar J, Bonichon F et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J. Clin. Oncol. 22(20), 4040-4050 (2004).
-
(2004)
J. Clin. Oncol
, vol.22
, Issue.20
, pp. 4040-4050
-
-
Guillou, L.1
Benhattar, J.2
Bonichon, F.3
-
20
-
-
1342267079
-
Amplification of chromosome 1 sequences in lipomatous tumours and other sarcomas
-
Nilsson M, Meza-Zepeda LA, Mertens F, Forus A, Myidebost O, Mandahl N. Amplification of chromosome 1 sequences in lipomatous tumours and other sarcomas. Int. J. Cancer 109, 363-169 (2004).
-
(2004)
Int. J. Cancer
, vol.109
, pp. 363-169
-
-
Nilsson, M.1
Meza-Zepeda, L.A.2
Mertens, F.3
Forus, A.4
Myidebost, O.5
Mandahl, N.6
-
21
-
-
15644363454
-
Gain-of-Function mutations of c-kit in human gastrointestinal stromal tumours
-
Hirota S, Isozaki K, Moriyama Y et al. Gain-of-Function mutations of c-kit in human gastrointestinal stromal tumours. Science 279(5350), 577-580 (1988).
-
(1988)
Science
, vol.279
, Issue.5350
, pp. 577-580
-
-
Hirota, S.1
Isozaki, K.2
Moriyama, Y.3
-
22
-
-
0030793556
-
P-glycoprotein expression in soft-tissue sarcomas
-
Nakanishi H, Myoui A, Ochi T, Aozasa K. P-glycoprotein expression in soft-tissue sarcomas. J. Cancer Res. Clin. Oncol. 123(6), 352-356 (1997).
-
(1997)
J. Cancer Res. Clin. Oncol
, vol.123
, Issue.6
, pp. 352-356
-
-
Nakanishi, H.1
Myoui, A.2
Ochi, T.3
Aozasa, K.4
-
23
-
-
0029787736
-
Evaluation of P-glycoprotein expression in soft tissue sarcomas of the extremities
-
Serra M, Scotlandi K, Manara MC et al. Evaluation of P-glycoprotein expression in soft tissue sarcomas of the extremities. Cytotechnology 19(3), 253-256 (1996).
-
(1996)
Cytotechnology
, vol.19
, Issue.3
, pp. 253-256
-
-
Serra, M.1
Scotlandi, K.2
Manara, M.C.3
-
24
-
-
0032771412
-
Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas
-
Hoffmann J, Schmidt-Peter P, Hansch W et al. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas. Clin. Cancer Res. 5, 2198-2204 (1999).
-
(1999)
Clin. Cancer Res
, vol.5
, pp. 2198-2204
-
-
Hoffmann, J.1
Schmidt-Peter, P.2
Hansch, W.3
-
25
-
-
0033568161
-
Multidrug resistance phenotype in high grade soft tissue sarcomas
-
Jimenez RE, Zalupski MM, Frank JJ, Du W, Ryan JR, Lucas DR. Multidrug resistance phenotype in high grade soft tissue sarcomas. Cancer 86(6), 976-981 (1999).
-
(1999)
Cancer
, vol.86
, Issue.6
, pp. 976-981
-
-
Jimenez, R.E.1
Zalupski, M.M.2
Frank, J.J.3
Du, W.4
Ryan, J.R.5
Lucas, D.R.6
-
26
-
-
0037070754
-
Molecular characterisation of soft tissue tumours: A gene expression study
-
Nielsen TO, West RB, Linn SC et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 359, 1301-1307 (2002).
-
(2002)
Lancet
, vol.359
, pp. 1301-1307
-
-
Nielsen, T.O.1
West, R.B.2
Linn, S.C.3
-
27
-
-
0037531733
-
Gene expression analysis of human soft tissue leiomyosarcomas
-
Ren B, Yu YP, Jing L et al. Gene expression analysis of human soft tissue leiomyosarcomas. Hum. Pathol. 34(6), 549-558 (2003).
-
(2003)
Hum. Pathol
, vol.34
, Issue.6
, pp. 549-558
-
-
Ren, B.1
Yu, Y.P.2
Jing, L.3
-
28
-
-
0036840271
-
Expression profiling of synovial sarcoma by cDNA microarrays: Association of ERBB2, IGFBP2 and ELF3 with epithelial differentiation
-
Allander SV, Illei PB, Chen Y et al. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2 and ELF3 with epithelial differentiation. Am. J. Pathol. 161(5), 1587-1595 (2002).
-
(2002)
Am. J. Pathol
, vol.161
, Issue.5
, pp. 1587-1595
-
-
Allander, S.V.1
Illei, P.B.2
Chen, Y.3
-
29
-
-
0037821226
-
Molecular and immunohistochemical analysis of HER2/neu oncogene in synovial sarcoma
-
Nuciforo PG, Pellegrini C, Fasani R et al. Molecular and immunohistochemical analysis of HER2/neu oncogene in synovial sarcoma. Hum. Pathol. 34(7), 639-645 (2003).
-
(2003)
Hum. Pathol
, vol.34
, Issue.7
, pp. 639-645
-
-
Nuciforo, P.G.1
Pellegrini, C.2
Fasani, R.3
-
30
-
-
0036449341
-
Oncoproteins and proliferation markers in synovial sarcomas: A dinicopathological study of 19 cases
-
Barbashini V, Benevenia J, Aviv H et al. Oncoproteins and proliferation markers in synovial sarcomas: a dinicopathological study of 19 cases. J. Res. Clin. Oncol. 128(11), 610-616 (2002).
-
(2002)
J. Res. Clin. Oncol
, vol.128
, Issue.11
, pp. 610-616
-
-
Barbashini, V.1
Benevenia, J.2
Aviv, H.3
-
31
-
-
25844472319
-
C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck
-
Olsen RJ, Lydiatt WM, Koepsell SA et al. C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck. Head Neck 27(10), 883-892 (2005).
-
(2005)
Head Neck
, vol.27
, Issue.10
, pp. 883-892
-
-
Olsen, R.J.1
Lydiatt, W.M.2
Koepsell, S.A.3
-
32
-
-
27644516035
-
Her-2 oncogene amplification, chromosome 17 and DNA ploidy status in synovial sarcoma
-
Sapi Z, Papai Z, Hruska A, Antal I, Bodo M, Orosz Z. Her-2 oncogene amplification, chromosome 17 and DNA ploidy status in synovial sarcoma. Pathol. Oncol. Res. 11(3), 133-138 (2005).
-
(2005)
Pathol. Oncol. Res
, vol.11
, Issue.3
, pp. 133-138
-
-
Sapi, Z.1
Papai, Z.2
Hruska, A.3
Antal, I.4
Bodo, M.5
Orosz, Z.6
-
33
-
-
13444291031
-
Expression of receptor tyrosine kinases, epidermal growth factor receptor and HER-2/neu in synovial sarcoma
-
Thomas DG, Giordano TJ, Sanders D et al. Expression of receptor tyrosine kinases, epidermal growth factor receptor and HER-2/neu in synovial sarcoma. Cancer 103(4), 830-838 (2005).
-
(2005)
Cancer
, vol.103
, Issue.4
, pp. 830-838
-
-
Thomas, D.G.1
Giordano, T.J.2
Sanders, D.3
-
34
-
-
23044509650
-
Hsp 90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro models
-
Terry J, Lubieniecka JM, Kwan W, Liu S, Nielsen TO. Hsp 90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro models. Clin. Cancer Res. 11(15), 5631-5638 (2005).
-
(2005)
Clin. Cancer Res
, vol.11
, Issue.15
, pp. 5631-5638
-
-
Terry, J.1
Lubieniecka, J.M.2
Kwan, W.3
Liu, S.4
Nielsen, T.O.5
-
35
-
-
0028108985
-
Database of p53 gene somatic mutations in human tumours and cell lines
-
Hollstein M, Rice K, Greenblatt MS et al. Database of p53 gene somatic mutations in human tumours and cell lines. Nucleic Acids Res. 22, 3551-3555 (1994).
-
(1994)
Nucleic Acids Res
, vol.22
, pp. 3551-3555
-
-
Hollstein, M.1
Rice, K.2
Greenblatt, M.S.3
-
36
-
-
0030948143
-
p53 gene mutations and p53 protein expression in human soft tissue sarcomas
-
Yoo J, Lee HK, Kang CS, Park WS, Lee JY, Shim SI. p53 gene mutations and p53 protein expression in human soft tissue sarcomas. Arch. Pathol. Lab. Med. 121(4), 395-399 (1997).
-
(1997)
Arch. Pathol. Lab. Med
, vol.121
, Issue.4
, pp. 395-399
-
-
Yoo, J.1
Lee, H.K.2
Kang, C.S.3
Park, W.S.4
Lee, J.Y.5
Shim, S.I.6
-
37
-
-
0027944206
-
p53 status and the efficacy of cancer therapy in vivo
-
Lowe SW, Bodis S, McClatchey A et al. p53 status and the efficacy of cancer therapy in vivo. Science 266, 807-810 (1994).
-
(1994)
Science
, vol.266
, pp. 807-810
-
-
Lowe, S.W.1
Bodis, S.2
McClatchey, A.3
-
38
-
-
0034930374
-
Apoptosis is critical for drug response in vivo
-
Schmitt CA, Lowe SW. Apoptosis is critical for drug response in vivo. Drug Resist. Updat. 4, 132-134 (2001).
-
(2001)
Drug Resist. Updat
, vol.4
, pp. 132-134
-
-
Schmitt, C.A.1
Lowe, S.W.2
-
39
-
-
0037169358
-
Apoptosis: A link between camcer genetics and chemotherapy
-
Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between camcer genetics and chemotherapy. Cell 108, 153-164 (2002).
-
(2002)
Cell
, vol.108
, pp. 153-164
-
-
Johnstone, R.W.1
Ruefli, A.A.2
Lowe, S.W.3
-
40
-
-
0033552948
-
Mutant p53 gain of function: Differential effects of different p53 mutations on resistance of cultured cells to chemotherapy
-
Blandino G, Levine AJ, Oren M. Mutant p53 gain of function: differential effects of different p53 mutations on resistance of cultured cells to chemotherapy. Oncogene 18, 477-485 (1999).
-
(1999)
Oncogene
, vol.18
, pp. 477-485
-
-
Blandino, G.1
Levine, A.J.2
Oren, M.3
-
41
-
-
0035866772
-
Influence of TP53 gene alterations and c-erb-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer
-
Geisler S, Lonning PE, Aas T et al. Influence of TP53 gene alterations and c-erb-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Cancer Res. 61, 2505-2512 (2001).
-
(2001)
Cancer Res
, vol.61
, pp. 2505-2512
-
-
Geisler, S.1
Lonning, P.E.2
Aas, T.3
-
42
-
-
0037363440
-
A mutant TP53 gene status is associated with a poor prognosis and anthracycline resistance in breast cancer
-
Rahko E, Blanco G, Soini Y, Bloigu R, Jukkola A. A mutant TP53 gene status is associated with a poor prognosis and anthracycline resistance in breast cancer. Eur. J. Cancer 39, 447-453 (2003).
-
(2003)
Eur. J. Cancer
, vol.39
, pp. 447-453
-
-
Rahko, E.1
Blanco, G.2
Soini, Y.3
Bloigu, R.4
Jukkola, A.5
-
43
-
-
0027244853
-
The p53-mdm-2 autoregulatory feedback loop
-
Wu X, Bayle H, Olson D, Levine AJ. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7, 1126-1132 (1993).
-
(1993)
Genes Dev
, vol.7
, pp. 1126-1132
-
-
Wu, X.1
Bayle, H.2
Olson, D.3
Levine, A.J.4
-
44
-
-
1042274013
-
Amplification of the MDM2 gene, but not expression of splice variants of MDM2 RNA, is associated with prognosis in soft tissue sarcoma
-
Bartel F, Meye A, Wurl P et al. Amplification of the MDM2 gene, but not expression of splice variants of MDM2 RNA, is associated with prognosis in soft tissue sarcoma. Int. J. Cancer 95, 168-175 (2001).
-
(2001)
Int. J. Cancer
, vol.95
, pp. 168-175
-
-
Bartel, F.1
Meye, A.2
Wurl, P.3
-
45
-
-
0032145989
-
The MDM2 gene amplification database
-
Momand J, Jung D, Wilczynski S, Niland J. The MDM2 gene amplification database. Nucleic Acid Res. 26(15), 3453-3459 (1998).
-
(1998)
Nucleic Acid Res
, vol.26
, Issue.15
, pp. 3453-3459
-
-
Momand, J.1
Jung, D.2
Wilczynski, S.3
Niland, J.4
-
46
-
-
0032517341
-
INK4a/CDKN2A tumor suppressor and its relatives
-
INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1378(2), 115-177 (1998).
-
(1998)
Biochim. Biophys. Acta
, vol.1378
, Issue.2
, pp. 115-177
-
-
Ruas, M.1
Peters, G.2
-
47
-
-
0035958571
-
Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer
-
Silva J, DominguezG, Silva JM et al. Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer. Oncogene 20, 4586-4590 (2001).
-
(2001)
Oncogene
, vol.20
, pp. 4586-4590
-
-
Silva, J.1
Dominguez, G.2
Silva, J.M.3
-
48
-
-
0034745338
-
ARF deletion and methylation in genetic pathways to glioblastomas
-
ARF deletion and methylation in genetic pathways to glioblastomas. Brain Pathol, 11, 159-168 (2001).
-
(2001)
Brain Pathol
, vol.11
, pp. 159-168
-
-
Nakamura, M.1
Watanabe, T.2
Klangby, U.3
-
49
-
-
0032549704
-
ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53
-
ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713-723 (1998).
-
(1998)
Cell
, vol.92
, pp. 713-723
-
-
Pomerantz, J.1
Schreiber-Agus, N.2
Liegeois, L.3
-
50
-
-
0033521621
-
ARF with Mdm2 inhibits ubiquitin ligase activity of MDM2 for tumour supressor p53
-
ARF with Mdm2 inhibits ubiquitin ligase activity of MDM2 for tumour supressor p53. EMBO J. 18, 22-27 (1999).
-
(1999)
EMBO J
, vol.18
, pp. 22-27
-
-
Honda, R.1
Yasuda, H.2
-
51
-
-
0034017956
-
Cooperative signals governing ARF-Mdm2 interaction and nucleolar localisation of the complex
-
Weber JD, Koo M-L, Bothner B et al. Cooperative signals governing ARF-Mdm2 interaction and nucleolar localisation of the complex. Mol. Cell Biol. 20, 2517-2528 (2000).
-
(2000)
Mol. Cell Biol
, vol.20
, pp. 2517-2528
-
-
Weber, J.D.1
Koo, M.-L.2
Bothner, B.3
-
52
-
-
0034984614
-
Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumours
-
Lopez-Guerrero JA, Pellin A, Noguera R, Carda C, Llombart-Bosch A. Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumours. Lab. Invest. 81(6), 803-814 (2001).
-
(2001)
Lab. Invest
, vol.81
, Issue.6
, pp. 803-814
-
-
Lopez-Guerrero, J.A.1
Pellin, A.2
Noguera, R.3
Carda, C.4
Llombart-Bosch, A.5
-
53
-
-
0034661248
-
Analysis of the p16INK4, P14ARF, P15, TP53, and MDM2 genes and their prognostic ?indications in osteosarcoma and Ewing sarcoma
-
Tsuchiya T, Sekine K, Hinohara S, Namiki T, Nobori T, Kaneko Y. Analysis of the p16INK4, P14ARF, P15, TP53, and MDM2 genes and their prognostic ?indications in osteosarcoma and Ewing sarcoma. Cancer Genet. Cytogenet. 120, 91-98 (2000).
-
(2000)
Cancer Genet. Cytogenet
, vol.120
, pp. 91-98
-
-
Tsuchiya, T.1
Sekine, K.2
Hinohara, S.3
Namiki, T.4
Nobori, T.5
Kaneko, Y.6
-
54
-
-
0033528084
-
Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: Effect on survival
-
Orlow I, Dtobnjak M, Zhang ZF et al. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival. J. Natl Cancer Inst. 91(1), 73-79 (1999).
-
(1999)
J. Natl Cancer Inst
, vol.91
, Issue.1
, pp. 73-79
-
-
Orlow, I.1
Dtobnjak, M.2
Zhang, Z.F.3
-
55
-
-
9544244796
-
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer
-
Roth JA, Nguyen D, Lawerence DD et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat. Med. 2, 985-991 (1996).
-
(1996)
Nat. Med
, vol.2
, pp. 985-991
-
-
Roth, J.A.1
Nguyen, D.2
Lawerence, D.D.3
-
56
-
-
0032988319
-
Regulation of p53 protein function through alterations in protein-following pathways
-
Hupp TR. Regulation of p53 protein function through alterations in protein-following pathways. Cell. Mol. Life Sci. 55, 88-95 (1999).
-
(1999)
Cell. Mol. Life Sci
, vol.55
, pp. 88-95
-
-
Hupp, T.R.1
-
58
-
-
0041672549
-
Reactivation of mutant p53 by a one-hybrid adaptor protein
-
Roth J, Lenz-Bauer C, Contente A et al. Reactivation of mutant p53 by a one-hybrid adaptor protein. Cancer Res. 63, 3904-3908 (2003).
-
(2003)
Cancer Res
, vol.63
, pp. 3904-3908
-
-
Roth, J.1
Lenz-Bauer, C.2
Contente, A.3
-
59
-
-
0037314655
-
Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumours with correlative p53 studies
-
Makower D, Rozenblit A, Kaufman H et al. Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumours with correlative p53 studies. Clin. Cancer Res. 9, 693-702 (2003).
-
(2003)
Clin. Cancer Res
, vol.9
, pp. 693-702
-
-
Makower, D.1
Rozenblit, A.2
Kaufman, H.3
-
60
-
-
20144368516
-
Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas
-
Galanis E, Okuno SH, Nascimiento AG et al. Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas. Gene Therapy 12(5), 437-445 (2005).
-
(2005)
Gene Therapy
, vol.12
, Issue.5
, pp. 437-445
-
-
Galanis, E.1
Okuno, S.H.2
Nascimiento, A.G.3
-
61
-
-
10744221485
-
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
-
Vassilev LT, Vu BT, Graves B et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844-848 (2004).
-
(2004)
Science
, vol.303
, pp. 844-848
-
-
Vassilev, L.T.1
Vu, B.T.2
Graves, B.3
-
62
-
-
32444449180
-
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
-
Tovar C, Rosinski J, Filipovic Z et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc. Natl Acad. Sci. USA 7(103), 1659-1660 (2006).
-
(2006)
Proc. Natl Acad. Sci. USA
, vol.7
, Issue.103
, pp. 1659-1660
-
-
Tovar, C.1
Rosinski, J.2
Filipovic, Z.3
-
63
-
-
12144291080
-
Use of c-KITPDGFRA mutational analysis to predict the clinical response to imarinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group
-
Debeic-Rychter M, Dumez H, Judson I et al. Use of c-KITPDGFRA mutational analysis to predict the clinical response to imarinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group. Eur. J. Cancer 10, 689-695 (2004).
-
(2004)
Eur. J. Cancer
, vol.10
, pp. 689-695
-
-
Debeic-Rychter, M.1
Dumez, H.2
Judson, I.3
-
64
-
-
0142121411
-
Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target: Results from an EORTC Soft Tissue and Bone Sarcoma Group Phase II study
-
Verweij J, van Oosterom A, Blay JY et al. Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target: results from an EORTC Soft Tissue and Bone Sarcoma Group Phase II study. Eur. J. Cancer 39, 2006-2011 (2003).
-
(2003)
Eur. J. Cancer
, vol.39
, pp. 2006-2011
-
-
Verweij, J.1
van Oosterom, A.2
Blay, J.Y.3
-
65
-
-
33646432734
-
Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumour mutants refractory to imatinib mesylate
-
Prenen H, Cools J, Mentens N et al. Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumour mutants refractory to imatinib mesylate. Clin. Cancer Res. 12(8), 2622-2627 (2006).
-
(2006)
Clin. Cancer Res
, vol.12
, Issue.8
, pp. 2622-2627
-
-
Prenen, H.1
Cools, J.2
Mentens, N.3
-
66
-
-
33749505836
-
Efficacy and safety of sunitinib in patients with advanced ga!trointestinal stromal tumour after failure of imatinib: A randomised controlled trial
-
Demetri GD, van Oosterom A, Garrett CR et al. Efficacy and safety of sunitinib in patients with advanced ga!trointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 368 (9544), 1329-1338 (2006).
-
(2006)
Lancet
, vol.368
, Issue.9544
, pp. 1329-1338
-
-
Demetri, G.D.1
van Oosterom, A.2
Garrett, C.R.3
-
67
-
-
0027438827
-
Combinatorial generation of variable fusion proteins in the ewing family of tumours
-
Zucman J, Melot T, Desmaze C et al. Combinatorial generation of variable fusion proteins in the ewing family of tumours. EMBO J. 12, 4481-4487 (1993).
-
(1993)
EMBO J
, vol.12
, pp. 4481-4487
-
-
Zucman, J.1
Melot, T.2
Desmaze, C.3
-
68
-
-
0023678656
-
Chromosomes in Ewings Sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12)
-
Turc-Carel C, Aurias A, Mugrieret F et al. Chromosomes in Ewings Sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet. Cytogenet. 32(2), 229-238 (1988).
-
(1988)
Cancer Genet. Cytogenet
, vol.32
, Issue.2
, pp. 229-238
-
-
Turc-Carel, C.1
Aurias, A.2
Mugrieret, F.3
-
69
-
-
0030028657
-
Fusion of an ETS-family gene, E1AF to EWS by t(17;22) (q12;q12) chromosome translocation in an undiferentiated sarcoma of infancy
-
Kaneko Y, Yoshida K, Handa M et al. Fusion of an ETS-family gene, E1AF to EWS by t(17;22) (q12;q12) chromosome translocation in an undiferentiated sarcoma of infancy. Genes Chromosomes Cancer 15, 115-121 (1996).
-
(1996)
Genes Chromosomes Cancer
, vol.15
, pp. 115-121
-
-
Kaneko, Y.1
Yoshida, K.2
Handa, M.3
-
70
-
-
0030975975
-
A new member of the ETS family fused to EWS in Ewing tumours
-
Peter M, Couturier J, Pacquement H et al. A new member of the ETS family fused to EWS in Ewing tumours. Oncogene 14, 1159-1164 (1997).
-
(1997)
Oncogene
, vol.14
, pp. 1159-1164
-
-
Peter, M.1
Couturier, J.2
Pacquement, H.3
-
71
-
-
0036479960
-
Detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases
-
Antonescu CR, Tschernyavsky SJ, Woodruff JM, Jungbluth AA, Brennan M, Ladanyi M. Detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases. J. Mol. Diagn. 4(1), 44-52 (2002).
-
(2002)
J. Mol. Diagn
, vol.4
, Issue.1
, pp. 44-52
-
-
Antonescu, C.R.1
Tschernyavsky, S.J.2
Woodruff, J.M.3
Jungbluth, A.A.4
Brennan, M.5
Ladanyi, M.6
-
72
-
-
0028895196
-
Oncogeneic conversion of a novel orphan nuclear receptor by chromosome translocation
-
Labelle Y, Zucman J, Stenman G et al. Oncogeneic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum. Mol. Genet. 4, 2219-2226 (1995).
-
(1995)
Hum. Mol. Genet
, vol.4
, pp. 2219-2226
-
-
Labelle, Y.1
Zucman, J.2
Stenman, G.3
-
73
-
-
0028246185
-
Fusion of the EWS and ET1 genes in the desmoplastic small round cell tumour
-
Ladanyi M, Gerald W. Fusion of the EWS and ET1 genes in the desmoplastic small round cell tumour. Cancer Res. 54, 2837-2840 (1994).
-
(1994)
Cancer Res
, vol.54
, pp. 2837-2840
-
-
Ladanyi, M.1
Gerald, W.2
-
74
-
-
0033791809
-
Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by the chromosomal translocation involving bands 12q13 and 16p11
-
Waters BL, Panagopoulos I, Allen EF. Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by the chromosomal translocation involving bands 12q13 and 16p11. Cancer Genet. Cytogenet. 121, 109-116 (2000).
-
(2000)
Cancer Genet. Cytogenet
, vol.121
, pp. 109-116
-
-
Waters, B.L.1
Panagopoulos, I.2
Allen, E.F.3
-
75
-
-
0036707752
-
Fusion of the FUS and ATF-1 genes in a large, deep-seated angiomatoid fibrous histiocytoma
-
Raddaoui E, Donner LR, Panagopoulos I. Fusion of the FUS and ATF-1 genes in a large, deep-seated angiomatoid fibrous histiocytoma. Diagn. Mol. Pathol. 11, 157-162 (2002).
-
(2002)
Diagn. Mol. Pathol
, vol.11
, pp. 157-162
-
-
Raddaoui, E.1
Donner, L.R.2
Panagopoulos, I.3
-
76
-
-
0035804224
-
The der(17)t(X;17)(p11;q25)of human alveolar soft part sarcoma fuses the TFE transcription factor gene to ASPL, a novel gene at 17q25
-
Ladanyi M, Lui MY, Antonescu CR et al. The der(17)t(X;17)(p11;q25)of human alveolar soft part sarcoma fuses the TFE transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 20, 48-57 (2001).
-
(2001)
Oncogene
, vol.20
, pp. 48-57
-
-
Ladanyi, M.1
Lui, M.Y.2
Antonescu, C.R.3
-
77
-
-
0033982373
-
Structural analysis of PAX7 rearrangements in alveolar rhadbomyosarcoma
-
Fitzgerald JC, Scherr AM, Barr FG. Structural analysis of PAX7 rearrangements in alveolar rhadbomyosarcoma. Cancer Genet. Cytogenet. 117(1), 37-40 (2000).
-
(2000)
Cancer Genet. Cytogenet
, vol.117
, Issue.1
, pp. 37-40
-
-
Fitzgerald, J.C.1
Scherr, A.M.2
Barr, F.G.3
-
78
-
-
0037402488
-
Genetics of dermatofibrosarcoma protuberans family of tumours: From ring chromosomes to tyrosine kinase inhibitor treatment
-
Sirvent N, Maire G, Pedctour F. Genetics of dermatofibrosarcoma protuberans family of tumours: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer 37, 1-19 (2003).
-
(2003)
Genes Chromosomes Cancer
, vol.37
, pp. 1-19
-
-
Sirvent, N.1
Maire, G.2
Pedctour, F.3
-
79
-
-
0031953233
-
A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma
-
Knezevich SR, McFadden DE, Tao W, Linm JF, Sorensen PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nature Genetics 18, 184-187 (1998).
-
(1998)
Nature Genetics
, vol.18
, pp. 184-187
-
-
Knezevich, S.R.1
McFadden, D.E.2
Tao, W.3
Linm, J.F.4
Sorensen, P.H.5
-
80
-
-
14344280487
-
Frequent hisign of the JAZF1 and JJAZ1 genes in endometrial stromal tumours
-
Koontz JI, Soreng AL, Nucci M et al. Frequent hisign of the JAZF1 and JJAZ1 genes in endometrial stromal tumours. Proc. Natl. Acad. Sci. USA 98(11), 6348-6353 (2001).
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, Issue.11
, pp. 6348-6353
-
-
Koontz, J.I.1
Soreng, A.L.2
Nucci, M.3
|